TY - JOUR T1 - Characterization of <em>PABPN1</em> expansion mutations in a large cohort of Mexican patients with oculopharyngeal muscular dystrophy (OPMD) JF - Journal of Investigative Medicine JO - J Investig Med SP - 705 LP - 708 DO - 10.1136/jim-2016-000184 VL - 65 IS - 3 AU - Marisa Cruz-Aguilar AU - Caroline Guerrero-de Ferran AU - Jose Luis Tovilla-Canales AU - Angel Nava-Castañeda AU - Juan C Zenteno Y1 - 2017/03/01 UR - http://hw-f5-jim.highwire.org/content/65/3/705.abstract N2 - Oculopharyngeal muscular dystrophy (OPMD) is an autosomal-dominant, adult-onset disorder defined by blepharoptosis, dysphagia, and proximal muscle weakness. OPMD arises from heterozygous expansions of a trinucleotide (GCN) tract situated at the 5′ region of the polyadenylate RNA binding protein 1 (PABPN1) gene. The frequency of a particular (GCN) expansion in a given population of patients with OPMD is largely influenced by the occurrence of founder mutations. Analysis of large groups of patients with OPMD from different ethnic origins will help to estimate the relative contribution of each expanded allele to the disease. The purpose of this study was to characterize the type of PABPN1 expanded alleles in a large cohort of OPMD individuals from Mexico. Molecular analysis procedures included genomic DNA extraction from blood leukocytes in each patient followed by PCR amplification of PABPN1 exon 1, and direct nucleotide sequencing of PCR products. A total of 102 patients with OPMD were included in the study. Expanded PABPN1 gene alleles were demonstrated in all patients: 65% (66 out of 102) had a (GCN)15 expansion while the remaining 35% (36 out of 102) exhibited a (GCN)13 expansion. This is one of the largest series of molecularly confirmed patients with OPMD in a non-Caucasian population. Ethnic-specific differences in the prevalence of specific PABPN1 expansions must be considered for genetic screening of patients with OPMD. ER -